Peters et al., Uptake of TDF-based ART among HIV/HBV co-infected patients
Uptake of tenofovir-based antiretroviral therapy among HIV/HBV co-infected patients in the EuroSIDA study. Antiviral Therapy Peters et al. on behalf of the EuroSIDA study aimed to study regional differences in uptake of tenofovir disoproxil fumarate (TDF-) based combination antiretroviral therapy (cART) and factors associated with its use among HIV/hepatitis B virus (HBV) co-infected patients across […]
Shepherd et al., Rauchstopp und Risiko von Krebs bei HIV-infizierten Personen
Rauchstopp und Risiko von Krebs bei HIV-infizierten Personen. Clinical Infectious Diseases. Dass Rauchen ungesund ist und das Risiko für Lungenkrebs deutlich erhöht, ist bestens untersucht. Weniger gut untersucht ist, in welchem Ausmass das Rauchen bei HIV-infizierten Personen zu einem Krebsrisiko beiträgt und wie lange es braucht, bis das Risiko für Lungenkrebs nach einem Rauchstopp […]
Shepherd et al., L’arrêt du tabac et le risque de cancer chez les personnes infectées par le VIH
L’arrêt du tabac et le risque de cancer chez les personnes infectées par le VIH. Clinical Infectious Diseases Le tabagisme nuit à la santé et augmente considérablement le risque du cancer du poumon. Nous ne disposons cependant que de peu d’informations sur l’effet du tabagisme sur le risque de cancer chez les séropositifs. Des […]
Gran et al., Estimating treatment effect under time-dependent confounding
Estimating the treatment effect on the treated under time-dependent confounding in an application to the Swiss HIV Cohort Study. Journal of the Royal Statistical Society When comparing time varying treatments in a non-randomized setting, one must often correct for time-dependent confounders that influence treatment choice over time and that are themselves influenced by treatment. […]
Shepherd et al., Interruzione del fumo e rischio di cancro nelle persone con infezione da HIV
Interruzione del fumo e rischio di cancro nelle persone con infezione da HIV. Clinical Infectious Diseases Il tabagismo nuoce alla salute e aumenta in modo sensibile il rischio di cancro dei polmoni. Ci sono pochi dati clinici sugli effetti del tabagismo in relazione al rischio di cancro nelle persone sieropositive. Studi precedenti nelle persone sieronegative […]
Shepherd et al., Risk factors for Non-Hodgkin and Hodgkin lymphoma
Differences in virological and immunological risk factors for Non-Hodgkin and Hodgkin lymphoma. Journal of the National Cancer Institution. Shepherd et al. on behalf of the Data Collection on Adverse events Cohort (D:A:D) aimed to identify independent risk factors of Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) and to identify factors that differentially affect NHL […]
Laut et al., Disparities in ART coverage and virological suppression across Europe
Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015. Eurosurveillance Laut et al. on behalf of the EuroSIDA Study Group aimed to characterize country-specific levels of antiretroviral therapy (ART) coverage and ART-induced HIV RNA suppression (HIV RNA < 500 copies/mL) within the EuroSIDA study, and to monitor temporal […]
Leon-Reyes et al., Estimation des frais de traitement pour les personnes atteintes du VIH en Suisse
Estimation des frais de traitement pour les personnes atteintes du VIH en Suisse. Clinical Infectious Diseases Des données fiables sur les coûts et l’utilisation des ressources de la santé publique sont indispensables pour évaluer les besoins actuels et futurs des séropositifs en Suisse. Les études sur les coûts induits par les traitements des out […]
Huges et al., Trends in CD4+:CD8+ ratio on ART
Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study. AIDS HIV infection leads to persistent immune activation and inflammation, which may accelerate deterioration of the immune system due to ageing (so called “immunosenescence”). In the general population, a low CD4+:CD8+ ratio is a surrogate […]
Leon-Reyes et al., Stima dei costi di trattamento per le persone con infezione HIV in Svizzera
Stima dei costi di trattamento per le persone con infezione HIV in Svizzera. Clinical Infectious Diseases Dati affidabili in relazione ai costi e all’utilizzazione delle risorse sanitarie sono indispensabili per valutare i bisogni attuali e futuri delle persone sieropositive in Svizzera. Gli studi sui costi indotti dalla presa in carico delle persone sieropositive seguite […]